We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of... Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19. Show more
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities...
Kostaive® anticipated to launch in Japan this year ARCT-032 remains on track for Phase 1b interim data in Q2 ARCT-810 remains on track for Phase 2 interim data by the end of Q2 ARCT-2138...
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease...
Access to protocol assistance, centralized authorization process, fee reductions and 10 years of market exclusivity Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT...
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease...
New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrate Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster PR Newswire KING OF PRUSSIA, Pa. and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.29 | -4.69774217043 | 27.46 | 28.8 | 25.41 | 428461 | 26.65202081 | CS |
4 | -6.87 | -20.7929782082 | 33.04 | 33.99 | 25.41 | 490235 | 30.22690505 | CS |
12 | -7.14 | -21.4350045032 | 33.31 | 43.81 | 25.41 | 495728 | 34.73254617 | CS |
26 | 6.4 | 32.3722812342 | 19.77 | 43.81 | 17.52 | 454545 | 30.54654487 | CS |
52 | -2.29 | -8.04638088545 | 28.46 | 43.81 | 17.52 | 432016 | 29.71376393 | CS |
156 | -10.22 | -28.084638637 | 36.39 | 64.9735 | 11.7 | 537911 | 29.13954799 | CS |
260 | 18.69 | 249.86631016 | 7.48 | 129.71 | 5.7 | 557169 | 39.11775315 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions